Insider Transactions in Q4 2024 at Eloxx Pharmaceuticals, Inc. (ELOX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
           
            Oct 16                          
            2024                          
           
         |           
        Sumit Aggarwal Director | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              165,000
              +49.26%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Oct 16                          
            2024                          
           
         |           
        Steven D Rubin Director | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              12,000
              +50.0%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Oct 16                          
            2024                          
           
         |           
        Lindsay Androski Director | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              12,000
              +50.0%
              
         |   
        
           
              -                 
                     
         | 
      
| 
           
            Oct 16                          
            2024                          
           
         |           
        Alan Edmund Walts Director | 
           
              BUY
             
            
                Grant, award, or other acquisition
             
           | 
        Direct | 
           
              12,000
              +48.11%
              
         |   
        
           
              -                 
                     
         |